Protracted results of dose-intensive therapy using cyclophosphamide, carmustine, and continuous infusion etoposide with autologous stem cell support in patients with relapse or refractory Hodgkin's disease: a phase II study from the North American Marrow Transplant Group.
暂无分享,去创建一个
R. Collins | J. Fay | J. Lynch | L. Goldsmith | R. Herzig | R. Stein | D. Fleming | S. Goodman | S. Wolff | G. Herzig | D. Stevens | R. Brown | B. Bolwell | J. Greer | L. Piñeiro | R. Brown